AtriCure (NASDAQ: ATRC) reported Q4 EPS of $0.06, $0.16 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $140.5 million versus the consensus estimate of $139.55 million.

GUIDANCE:

AtriCure sees FY2026 EPS of $0.09-$0.15, versus the consensus of ($0.03). AtriCure sees FY2026 revenue of $600-610 million, versus the consensus of $602 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.